Dyadic International

Dyadic International, Inc. (OTCQX: DYAI) is a global biotechnology corporation that focuses on enhancing and utilizing the patented and exclusive C1 expression system to expedite the delivery of biologic vaccines and medications to the market. This is done in larger quantities, at reduced cost, and with new properties, benefiting drug developers and manufacturers in enhancing patient access and reducing healthcare expenses, ultimately contributing to saving lives.